---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-008624"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2025-11-21T23:59:59+00:00"
generated_at: "2026-05-16T17:39:51.380967+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CNS Pharma shareholders approve 12x increase in authorized common shares to 300M and equity plan expansion

## Summary
- Authorized common stock increased from 25M to 300M shares; preferred from 416,667 to 5M shares.
- 2020 Equity Plan shares authorized increased by 114,916 to total 115,061 shares.
- All six director nominees elected: Climaco, Gumulka, Keyes, Charles, Cockroft, Mahery.
- MaloneBailey LLP ratified as independent auditor for FY 2025; say-on-pay approved with annual frequency.

## SEC filing metadata
- accession: 0001683168-25-008624
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2025-11-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 5.07, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316825008624/0001683168-25-008624-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316825008624/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-008624
- JSON: https://secwatch.observer/filing/0001683168-25-008624.json
- Plain text: https://secwatch.observer/filing/0001683168-25-008624.txt

## Source-grounded claims
- claim_id: d725ed412cca7536744942eb0989f973abbcb431
  claim: CNS Pharmaceuticals, Inc.: Amended articles to increase authorized common stock from 25,000,000 shares to 300,000,000 shares and preferred stock from 416,667 shares to 5,000,000 shares (effective 2025-11-20).
  evidence_excerpt: On November 20, 2025, the Company filed a Certificate of Amendment to its Amended and Restated Articles of Incorporation (the “Amendment”) with the Secretary of State of the State of Nevada to increase the number of the Company’s authorized shares of common stock from 25,000,000 shares to 300,000,000 shares and to increase the total number of authorized shares of preferred stock from 416,667 shares to 5,000,000 shares.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1729427/000168316825008624/0001683168-25-008624-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.